Reach Us +44-1647-403003
Sherry A. Bradford | OMICS International
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Relevant Topics

Sherry A. Bradford

Sherry A. Bradford Sherry A. Bradford
State University at Buffalo
New York
Tel: 7168607800


Dr. Bradford has a PhD in Medical Biochemistry-Oncology from the Roswell Park Cancer Institute, Division of SUNY at Buffalo School of Medical and Biomedical Sciences (on a full scholarship). She is the founder of AccuTheranostics and the inventor of the various patents. Founded the PROI Foundation to assist cancer patients; Co-Founder of S.S. Formulations (Skin Products). She was awarded the Award for Excellence in Research from the American Federation for Clinical Research, Business First – Women of Influence-Innovation Award, Business First – Who’s Who in Healthcare, Erie Community College Distinguished Alumni Award, [email protected] Buffalo Award for Excellence in Research Award – 1st Place, American Federation of Clinical Research Award – First Place, NYC and Award Roswell Park Cancer Institute Research Forum. She has authored many scientific papers and book chapters; and currently sits on two editorial boards; and been an invited speaker at many national and international meetings She is a member of many major professional cancer organizations including, ASCO, AACR and AAAS and a “grass-roots” member of the International Metabolic Cancer Group. As Chief Scientific Officer, she guides the day-to-day research directives as well as the clinical laboratory operations. She specializes in the field of cancer research and treatment, determined to make a meaningful difference in the lives of those faced with the disease. Her overall vision is to develop a state-of-the-art clinical laboratory to empower patients in determining and deciding their course of therapy eventuating into a positive outcome concurrent with quality-of-life; demonstrated through her initiatives of research individualized personal medicine assessment technologies that translate into the clinical setting.

Research Interest

Chemotherapy, Ovarian cancer


Global Speakers in the subject

Global Experts in the subject